Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1QPQ

Structure of Quinolinic Acid Phosphoribosyltransferase from Mycobacterium Tuberculosis: A Potential TB Drug Target

1QPQ の概要
エントリーDOI10.2210/pdb1qpq/pdb
分子名称QUINOLINATE PHOSPHORIBOSYLTRANSFERASE, SULFATE ION, QUINOLINIC ACID, ... (4 entities in total)
機能のキーワードtype ii prtase, de novo nad biosynthesis, prpp, phosphoribosyl transferase, quinolinic acid, structural genomics, psi, protein structure initiative, tb structural genomics consortium, tbsgc, transferase
由来する生物種Mycobacterium tuberculosis H37Rv
タンパク質・核酸の鎖数6
化学式量合計180684.27
構造登録者
Sharma, V.,Grubmeyer, C.,Sacchettini, J.C.,TB Structural Genomics Consortium (TBSGC) (登録日: 1998-11-20, 公開日: 1998-11-25, 最終更新日: 2023-12-27)
主引用文献Sharma, V.,Grubmeyer, C.,Sacchettini, J.C.
Crystal structure of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis: a potential TB drug target.
Structure, 6:1587-1599, 1998
Cited by
PubMed Abstract: . Mycobacterium tuberculosis is the single most deadly human pathogen and is responsible for nearly three million deaths every year. Recent elucidation of the mode of action of isoniazid, a frontline antimycobacterial drug, suggests that NAD metabolism is extremely critical for this microorganism. M. tuberculosis depends solely on the de novo pathway to meet its NAD demand. Quinolinic acid phosphoribosyltransferase (QAPRTase), a key enzyme in the de novo biosynthesis of NAD, provides an attractive target for designing novel antitubercular drugs.
PubMed: 9862811
DOI: 10.1016/S0969-2126(98)00156-7
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.45 Å)
構造検証レポート
Validation report summary of 1qpq
検証レポート(詳細版)ダウンロードをダウンロード

239149

件を2025-07-23に公開中

PDB statisticsPDBj update infoContact PDBjnumon